Gloria Biosciences
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A commercial-stage oncology company marketing and developing antibody therapies in China.
Oncology
Technology Platform
An integrated biopharmaceutical platform encompassing antibody development, manufacturing, and commercialization for the oncology market.
Opportunities
Opportunity to leverage commercial infrastructure to in-license or co-develop additional oncology assets for the Chinese market.
Risk Factors
Revenue concentration risk if overly dependent on a single marketed product facing pricing pressure or competition.
Competitive Landscape
Competes in the competitive and price-sensitive Chinese oncology market with both innovative and biosimilar products.